text: (R)-Roscovitine (<< CYC202 >>, Seliciclib) is a relatively selective inhibitor of cyclin-dependent kinases ([[ CDKs ]]), currently evaluated for the treatment of cancers, neurodegenerative disorders, renal diseases, and several viral infections.